Compare Indomobil Sukses Internasional Tbk. (IMAS) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indomobil Sukses Internasional Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Indomobil Sukses Internasional Tbk. trades at Rp900 (market cap 3.67T, 258K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Indomobil Sukses Internasional Tbk. is far larger — about 35.2× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| IMAS | SCPI | |
|---|---|---|
Market Cap | 3.67T | 104.4B |
Volume | 258K | — |
Lot | 2.58K | — |
Turnover | 231.83M | — |
Average Price | 898.55 | — |
Value | 231.83M | — |
Indicative Equilibrium Price | 900 | — |
Indicative Equilibrium Volume | 236 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indomobil Sukses Internasional Tbk.
PT Indomobil Sukses International Tbk (the Company) was initially established as a result of the merger between PT Indomulti Inti Industri Tbk (IMII) and PT Indomobil Investment corporation (IIC). The Company’s articles of association has been amended from time to time, most recently on June 30, 1999 in connection with the Company’s plans to offer shares with pre-emptive right. The Ministry of Justice has approved the amendment on July 5, 1999.
Read more on IMAS →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
